Results 31 to 40 of about 644,429 (317)
Bivalirudin during primary PCI in acute myocardial infarction. [PDF]
, 2008 BACKGROUND: Treatment with the direct thrombin inhibitor bivalirudin, as compared with heparin plus glycoprotein IIb/IIIa inhibitors, results in similar suppression of ischemia while reducing hemorrhagic complications in patients with stable angina and ...Kirtane, Ajay J, Wong, S Chiu, Parise, Helen, Witzenbichler, Bernhard, Pocock, Stuart J, HORIZONS-AMI Trial Investigators, Stone, Gregg W, Hartmann, Franz, Dudek, Dariusz, Gersh, Bernard J, Peruga, Jan Z, Guagliumi, Giulio, Brodie, Bruce R, Dangas, George, Kornowski, Ran, Mehran, Roxana +15 morecore +1 more sourceIncidence and predictors of left ventricular function change following ST-segment elevation myocardial infarction
Frontiers in Cardiovascular Medicine, 2023 AimThe purpose of the study was to assess the incidence and predictors of left ventricular function change in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI.Methods312 patients with STEMI who received primary ...Chuanfen Liu, Chuanfen Liu, Chuanfen Liu, Meng Guo, Meng Guo, Meng Guo, Yuxia Cui, Yuxia Cui, Yuxia Cui, Manyan Wu, Manyan Wu, Manyan Wu, Hong Chen, Hong Chen, Hong Chen +14 moredoaj +1 more sourcePaclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. [PDF]
, 2009 BACKGROUND: There is no consensus regarding the safety and efficacy of drug-eluting stents, as compared with bare-metal stents, in patients with ST-segment elevation myocardial infarction who are undergoing primary percutaneous coronary intervention (PCI)Brodie, Bruce R., Wong, S Chiu, Peruga, Jan Z., Parise, Helen, Möckel, Martin, Stone, Gregg W., Pocock, Stuart J, Witzenbichler, Bernhard, HORIZONS-AMI Trial Investigators, Stone, Gregg W, Dudek, Dariusz, Kellock, Alison, Gersh, Bernard J, Peruga, Jan Z, Lansky, Alexandra J, Ochala, Andrzej, Guagliumi, Giulio, Brodie, Bruce R, Lansky, Alexandra J., Pocock, Stuart J., Dangas, George, Gersh, Bernard J., Mehran, Roxana, Wong, S. Chiu +23 morecore +1 more sourceInhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size [PDF]
, 2021 Aims:
Identifying novel mediators of lethal myocardial reperfusion injury that can be targeted during primary percutaneous coronary intervention (PPCI) is key to limiting the progression of patients with ST-elevated myocardial infarction (STEMI) to ...Mangion, Kenneth, Lee, Mathew MY, Channon, Keith M, Good, Richard, Rocchiccioli, Paul, Nicklin, Stuart A., He, Weihong, Loughrey, Christopher M., Shaukat, Aadil, Petrie, Mark C, Elliott, Elspeth B, Nicklin, Stuart A, Channon, Keith M., Hood, Stuart, Nather, Katrin, Smith, Godfrey L, Elliott, Elspeth B., Carrick, David, Lee, Mathew M.Y., Davie, Andrew, O’Toole, Dylan, Lee, Mathew M Y, McCarroll, Charlotte S., Hawksby, Catherine, Loughrey, Christopher M, Petrie, Mark C., Oldroyd, Keith G., McArthur, Lisa, Martin, Tamara, McEntegart, Margaret, McClure, John, Smith, Godfrey L., Berry, Colin, Zaeri, Ali, Oldroyd, Keith G, Riddell, Alexandra, O'Toole, Dylan, Lindsay, Mitchell M., McCarroll, Charlotte S, Corcoran, David, Watkins, Stuart, Lindsay, Mitchell M, Eteiba, Hany, Ford, Kristopher +43 morecore +1 more sourceEfficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017 BackgroundIMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) showed that adding the nonstatin ezetimibe to statin therapy further reduced cardiovascular events in patients after an acute coronary syndrome. In a prespecified Eri Toda Kato, Christopher P. Cannon, Michael A. Blazing, Erin Bohula, Sema Guneri, Jennifer A. White, Sabina A. Murphy, Jeong‐Gun Park, Eugene Braunwald, Robert P. Giugliano +9 moredoaj +1 more sourceNeuropeptide‐Y levels in ST‐segment–elevation myocardial infarction: relationship with coronary microvascular function, heart failure, and mortality
, 2022 Background
The sympathetic cotransmitter, neuropeptide Y (NPY), is released into the coronary sinus during ST‐segment–elevation myocardial infarction and can constrict the coronary microvasculature.Choudhury, Robin P, Burrage, Matthew K, Channon, Keith M, Neubauer, Stefan, Ferreira, Vanessa M, Kharbanda, Rajesh K., Kharbanda, Rajesh K, Tapoulal, Nidi, Banning, Adrian P, Borlotti, Alessandra, Gibbs, Thomas, Channon, Keith M., Shanmuganathan, Mayooran, Banning, Adrian P., Burrage, Matthew K., Choudhury, Robin P., Herring, Neil, Ferreira, Vanessa M. +17 morecore +1 more sourceAltered gene expression pattern in peripheral blood mononuclear cells in patients with acute myocardial infarction. [PDF]
, 2012 In the acute phase of STEMI, dozens of genes from several pathways linked with lipid/glucose metabolism, platelet function and atherosclerotic plaque stability show altered expression.Burzynska, Beata, Marek Kiliszek (117207), Beata Burzynska, Janusz Kochanowski (117216), Agata Maciejak (117213), Leszczynska, Agata, Grzegorz Opolski (117217), Aleksandra Winkler, Ewa Gajda, Grzegorz Opolski, Beata Burzynska (117208), Ewa Gajda (117215), Marek Kiliszek, Agata Leszczynska, Janusz Kochanowski, Agata Leszczynska (117214), Monika Gora, Marcin Michalak, Kochanowski, Janusz, Monika Gora (117210), Marcin Michalak (117209), Michalak, Marcin, Gajda, Ewa, Agata Maciejak, Winkler, Aleksandra, Maciejak, Agata, Aleksandra Winkler (117212), Kiliszek, Marek, Opolski, Grzegorz, Gora, Monika +29 morecore +1 more sourceRed blood cell eNOS is cardioprotective in acute myocardial infarction
Redox Biology, 2022 Red blood cells (RBCs) were shown to transport and release nitric oxide (NO) bioactivity and carry an endothelial NO synthase (eNOS). However, the pathophysiological significance of RBC eNOS for cardioprotection in vivo is unknown.Miriam M. Cortese-Krott, Tatsiana Suvorava, Francesca Leo, Sophia K. Heuser, Anthea LoBue, Junjie Li, Stefanie Becher, Rebekka Schneckmann, Tanu Srivrastava, Ralf Erkens, Georg Wolff, Joachim P. Schmitt, Maria Grandoch, Jon O. Lundberg, John Pernow, Brant E. Isakson, Eddie Weitzberg, Malte Kelm +17 moredoaj +1 more sourceClopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction--a hospital registry-primary care linked cohort (MINAP-GPRD). [PDF]
, 2011 AIMS: Adherence to evidence-based treatments and its consequences after acute myocardial infarction (MI) are poorly defined. We examined the extent to which clopidogrel treatment initiated in hospital is continued in primary care; the factors predictive ...Van Staa, Tjeerd; id_orcid, K. A. A. Fox, Hemingway, Harry, Boggon, Rachael, van Staa, TP, H. Hemingway, Boggon, R, Begg, Alan, Fox, KAA, Ray, KK, Emmas, C, Timmis, A, T. P. van Staa, A. Begg, Begg, A, R. Boggon, C. Emmas, Fox, Keith A A, Fox, Keith AA, Ray, Kausik K, K. K. Ray, Emmas, Cathy, van Staa, Tjeerd P, Timmis, Adam, Hemingway, H, A. Timmis +25 morecore +1 more source